REVLIMID® (lenalidomide) AND POMALYST®/IMNOVID® (pomalidomide) REMAIN FOCUS OF COMBINATION THERAPIES IN MULTIPLE MYELOMA AT ASCO

REVLIMID® (lenalidomide) AND POMALYST®/IMNOVID® (pomalidomide) REMAIN FOCUS OF COMBINATION THERAPIES IN MULTIPLE MYELOMA AT ASCO